Resmed Inc Stock Performance
| RMD Stock | USD 255.77 0.03 0.01% |
The company holds a Beta of 0.62, which implies possible diversification benefits within a given portfolio. As returns on the market increase, ResMed's returns are expected to increase less than the market. However, during the bear market, the loss of holding ResMed is expected to be smaller as well. At this point, ResMed Inc has a negative expected return of -0.11%. Please make sure to check ResMed's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if ResMed Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ResMed Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 2.11 | Five Day Return 4.59 | Year To Date Return 11.96 | Ten Year Return 329.63 | All Time Return 38 K |
Forward Dividend Yield 0.0096 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 2.4 | Dividend Date 2025-12-18 |
1 | Disposition of 8009 shares by Michael Farrell of ResMed at 101.64 subject to Rule 16b-3 | 09/08/2025 |
| ResMed dividend paid on 18th of September 2025 | 09/18/2025 |
2 | Resmed Stock Up on Q1 Earnings Revenue Beat, Margins Expand | 10/31/2025 |
3 | Disposition of 2000 shares by Brett Sandercock of ResMed at 101.64 subject to Rule 16b-3 | 11/03/2025 |
4 | Nyxoah Secures Financing Commitments of up to U.S. 77 Million to Drive U.S. Commercialization of Genio | 11/14/2025 |
5 | Resmed CEO Mick Farrell on new technologies, tariffs and AI | 11/17/2025 |
6 | The Overnight Report Nvidia Beat Raise | 11/19/2025 |
7 | Cumberland Partners Ltd Has 3.35 Million Holdings in ResMed Inc. RMD | 11/20/2025 |
8 | My plan of attack for the next share market crash | 11/21/2025 |
9 | Disposition of 7297 shares by Michael Farrell of ResMed subject to Rule 16b-3 | 11/24/2025 |
| Begin Period Cash Flow | 238.4 M | |
| Total Cashflows From Investing Activities | -200 M |
ResMed Relative Risk vs. Return Landscape
If you would invest 27,473 in ResMed Inc on August 28, 2025 and sell it today you would lose (1,893) from holding ResMed Inc or give up 6.89% of portfolio value over 90 days. ResMed Inc is generating negative expected returns assuming volatility of 1.2232% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than ResMed, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
ResMed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ResMed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ResMed Inc, and traders can use it to determine the average amount a ResMed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0865
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RMD |
Estimated Market Risk
| 1.22 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ResMed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ResMed by adding ResMed to a well-diversified portfolio.
ResMed Fundamentals Growth
ResMed Stock prices reflect investors' perceptions of the future prospects and financial health of ResMed, and ResMed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ResMed Stock performance.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 36.06 B | ||||
| Shares Outstanding | 145.97 M | ||||
| Price To Earning | 73.48 X | ||||
| Price To Book | 5.98 X | ||||
| Price To Sales | 6.96 X | ||||
| Revenue | 5.15 B | ||||
| Gross Profit | 3.19 B | ||||
| EBITDA | 1.91 B | ||||
| Net Income | 1.4 B | ||||
| Cash And Equivalents | 1.21 B | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 851.81 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 2.80 X | ||||
| Book Value Per Share | 41.94 X | ||||
| Cash Flow From Operations | 1.75 B | ||||
| Earnings Per Share | 9.77 X | ||||
| Market Capitalization | 36.57 B | ||||
| Total Asset | 8.17 B | ||||
| Retained Earnings | 6.08 B | ||||
| Working Capital | 2.49 B | ||||
| Current Asset | 1.42 B | ||||
| Current Liabilities | 637.99 M | ||||
About ResMed Performance
By analyzing ResMed's fundamental ratios, stakeholders can gain valuable insights into ResMed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ResMed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ResMed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 161.91 | 162.57 | |
| Return On Tangible Assets | 0.30 | 0.32 | |
| Return On Capital Employed | 0.24 | 0.14 | |
| Return On Assets | 0.17 | 0.10 | |
| Return On Equity | 0.23 | 0.14 |
Things to note about ResMed Inc performance evaluation
Checking the ongoing alerts about ResMed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ResMed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ResMed Inc generated a negative expected return over the last 90 days | |
| ResMed Inc has a strong financial position based on the latest SEC filings | |
| About 66.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Disposition of 7297 shares by Michael Farrell of ResMed subject to Rule 16b-3 |
- Analyzing ResMed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ResMed's stock is overvalued or undervalued compared to its peers.
- Examining ResMed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ResMed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ResMed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ResMed's stock. These opinions can provide insight into ResMed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |